Skip to main content
. Author manuscript; available in PMC: 2022 Jun 17.
Published in final edited form as: Exp Eye Res. 2020 Nov 16;202:108361. doi: 10.1016/j.exer.2020.108361

Table 1.

Gene therapy clinical trials based on study classification as of 2017 (Ginn et al., 2017).

Classification Number of trials Percentage (%)

Cancer diseases 1688 65
Monogenic diseases 287 11.1
Infectious diseases 182 7
Cardiovascular diseases 180 6.9
Other diseases 58 2.2
Healthy volunteers 56 2.2
Gene marking 50 1.9
Neurological diseases 47 1.8
Ocular diseases 34 1.3
Inflammatory diseases 15 0.6